Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio (2021 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.38 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 11.67% to 0.38 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.38, a 11.67% increase, with the full-year FY2025 number at 0.43, up 21.18% from a year prior.
  • Asset Utilization Ratio was 0.38 for Q4 2025 at Rhythm Pharmaceuticals, down from 0.4 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.41 in Q2 2025 to a low of 0.0 in Q1 2021.
  • A 5-year average of 0.17 and a median of 0.11 in 2023 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 98.71% in 2022, then skyrocketed 189086.27% in 2023.
  • Rhythm Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2021, then plummeted by 98.71% to 0.0 in 2022, then surged by 189086.27% to 0.23 in 2023, then skyrocketed by 52.74% to 0.34 in 2024, then increased by 11.67% to 0.38 in 2025.
  • Per Business Quant, the three most recent readings for RYTM's Asset Utilization Ratio are 0.38 (Q4 2025), 0.4 (Q3 2025), and 0.41 (Q2 2025).